Sign In
Buy GH
$127.03
-3.14 (-2.41%)
At Close: Jun 03, 2026
Guardant Health (GH) Reports Q1 Loss, Tops Revenue Estimates
07:32pm, Thursday, 06'th May 2021
Guardant Health (GH) delivered earnings and revenue surprises of 40.24% and 5.85%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Guardant Health Appoints Craig Eagle, MD as Chief Medical Officer
08:05am, Monday, 03'rd May 2021
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announces the appointment of Craig Eagle, MD as the company's new Chief Medical Officer
Guardant Health to Participate in the BofA Securities 2021 Healthcare Conference
08:05am, Thursday, 29'th Apr 2021
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the upcoming BofA Securities 2021
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH) today announced a strategic collaboration with Daiichi Sankyo, Inc. (Daiichi Sankyo) to pursue regulatory approval and commerc
Disruptor Alert: These 2 Companies Are Changing Cancer Care
06:12am, Saturday, 24'th Apr 2021
Their liquid biopsies are giving doctors new and better tools to spot, track, and treat cancers.
Data at AACR Demonstrate Growing Clinical Utility of Guardant Health Liquid Biopsies in the Treatment and Management of Advanced Cancers
08:35am, Saturday, 10'th Apr 2021
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), along with leading academic institutions and pharmaceutical companies, presents new data at the AACR Virtual Annual Meeting I
Bear of the Day: Guardant Health (GH)
01:41pm, Tuesday, 06'th Apr 2021
Bear of the Day: Guardant Health (GH)
Why Guardant Health Stock Is Rising Today
11:05am, Thursday, 01'st Apr 2021
The company's newest product received a key approval in New York.
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH) announced that the New York State Department of Health Clinical Laboratory Evaluation Program (CLEP) has approved the Guardant
Guardant Health Receives ADLT Status from CMS for FDA-Approved Guardant360® CDx Test
08:05am, Tuesday, 30'th Mar 2021
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH) announced that the Centers for Medicare & Medicaid Services (CMS) has approved Advanced Diagnostic Laboratory Test (ADLT) stat
New Strong Sell Stocks for March 29th
12:06pm, Monday, 29'th Mar 2021
HTHT, FNLPF, GMRE, THRY, and GH have been added to the Zacks Rank #5 (Strong Sell) List on March 29, 2021
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, is joining forces with leading patient advocacy groups to expand the Clear Your View in
3 Extraordinary Diagnostics Stocks for 2021
07:33am, Sunday, 21'st Mar 2021
Innovation is risky, and these companies are all in.
Should Investors Be Worried About Guardant Health's Slowdown?
07:18am, Saturday, 13'th Mar 2021
The diagnostic testing company's growth may be slowing, but this shareholder isn't worried.
Why Guardant Health Stock Sank Today
03:21pm, Thursday, 04'th Mar 2021
The overall stock market sell-off pulled Guardant Health's shares down.
